Bayer Settles Novartis MS Drug Row for $200 Mln
Reuters.uk - UK
... before the anticipated submission in 2009 of its oral once-daily therapy FTY720 (fingolimod), which is currently in final-stage Phase III trials. ...
See all stories on this topic